Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
identified in Wound Booster, the sensors will also include known biophysical markers, and known inflammatory markers characteristic for CW. You will work in close collaboration with two other Empa PhD students
-
the Job related to staff position within a Research Infrastructure? No Offer Description PhD Position: Respiratory Dysfunction – Mechanisms and Impact on Performance and Quality of Life Exercise
-
are critical for human performance, with respiratory control and function of respiratory muscles playing a central role. This is particularly evident in patients with pulmonary, cardiac, or neuromuscular
-
The University of Basel, Switzerland, invites applications for a PhD researcher position (100% FTE) for the project Aspirational Urbanism and the Recodification of Defiance (ASPIRA). The function
-
of Basel, Swiss TPH combines research, education and services at local, national and international levels. 950 people from 95 nations work at Swiss TPH focusing on infectious and non-communicable diseases
-
agreement (preferably, 2025 Q2) Duration: Yearly contract for 3(+1) years, renewable based on performance and funding availability About the Position The successful candidate will contribute
-
. Empa is a research institution of the ETH Domain. The Laboratory of High Performance Ceramics is offering a PhD position focused on the development of new catalytic materials for CO2 conversion
-
on the interactions between autoreactive B cell, the lyphotropic virus EBV, and the cellular anatomy of the central nervous system. Work will involve both patient samples and experiments involving live animals
-
is a key-enabling technology for advanced manufacturing. In order to address increasingly complex demands on joining (dissimilar materials combinations, miniaturisation, extreme operation conditions
-
of this project, you will work with a team of scientists with backgrounds in chemistry, cell biology and microbiology as well as with clinical partners on the development of engineered corneal transplant to treat